ArticlePharmacoEconomics - open2022

Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland.

Elisabeth Brock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.